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ABSTRACT The binding sites of 5-HT3 and other Cys-loop receptors have been extensively studied, but there are no data on
the entry and exit routes of ligands for these sites. Here we have used molecular dynamics simulations to predict the pathway
for agonists and antagonists exiting from the 5-HT3 receptor binding site. The data suggest that the unbinding pathway follows a
tunnel at the interface of two subunits, which is ;8 A˚ long and terminates ;20 A˚ above the membrane. The exit routes for an
agonist (5-HT) and an antagonist (granisetron) were similar, with trajectories toward the membrane and outward from the ligand
binding site. 5-HT appears to form many hydrogen bonds with residues in the unbinding pathway, and experiments show that
mutating these residues signiﬁcantly affects function. The location of the pathway is also supported by docking studies of
granisetron, which show a potential binding site for granisetron on the unbinding route. We propose that leaving the binding
pocket along this tunnel places the ligands close to the membrane and prevents their immediate reentry into the binding pocket.
We anticipate similar exit pathways for other members of the Cys-loop receptor family.
INTRODUCTION
The 5-HT3 receptor is a member of the Cys-loop ligand-
gated ion channel family, which also includes nicotinic
acetylcholine (nACh), glycine, and g-aminobutyric acid type
A (GABAA) receptors. These proteins are responsible for
fast synaptic transmission, and are the targets of many
neuroactive drugs. Similar to other members of the Cys-loop
family, the 5-HT3 receptor forms a pentameric arrangement
of subunits (Fig. 1). Each subunit contains an extracellular
region and a transmembrane region. The transmembrane
region consists of four membrane-spanning a-helices, M1–
M4; the M2 segments from each of the ﬁve subunits forms
the lining of the central ion-conducting pore. A large loop
between M3 and M4 constitutes the majority of the intra-
cellular mass of the protein and is responsible for receptor
modulation and channel conductance. The extracellular re-
gion contains the ligand binding site, and there have been
numerous studies to identify the amino acids responsible for
receptor-ligand interactions. However, molecular details of
the complete receptor structure are still relatively undeﬁned.
This is largely because no high-resolution (x-ray crystallo-
graphic) structures of Cys-loop receptors have yet been
elucidated. Nonetheless, the structure of a protein homolo-
gous to the extracellular domain of the nACh receptor, the
acetylcholine binding protein (AChBP), has been resolved to
2.1 A˚ (1–3). This structure has proved useful for homology
models of this domain both in the nACh receptor and for
other Cys-loop receptors, and comparison with electron mi-
croscope data from the nACh receptor has indicated that
movement in this domain may trigger receptor gating (4).
Models and mutagenesis studies have shown that the
binding site for agonists and antagonists lies between the
faces of two adjacent subunits and is formed by the con-
vergence of three loops (A–C) from the principal subunit and
three loops (D–F) from the adjacent or complementary sub-
unit. Key residues in these loops in the homomeric 5-HT3A
receptor have been identiﬁed. As in all Cys-loop receptors,
the binding pocket of the 5-HT3 receptor contains a large
proportion of aromatic residues, reminiscent of the active site
of acetylcholinesterase (whose structure was resolved to 2.8
A˚ in 1991), which is located at the bottom of a gorge lined by
aromatic residues (5). The gorge residues are considered to
provide a rapid yet speciﬁc entry pathway for acetylcholine.
However, the entry and exit route(s) in the Cys-loop receptor
family have not yet been elucidated. This information is of
considerable importance, as the route of neurotransmitter
entry and/or exit has the potential to be a site of action of
neuroactive drugs, and mutations in amino acids in the path-
way could be responsible for receptor malfunction. Early
electron microscope images of the nACh receptor studies
showed the presence of ‘‘tunnels’’ between the large extra-
cellular vestibule of the receptor and the synaptic space, sug-
gesting that the neurotransmitter entry and/or exit route(s)
may be via the extracellular vestibule (6). However, the cur-
rent structural data do not support this hypothesis (4). The
aim of our work was to determine the exit route for the 5-HT3
receptor, a typical Cys-loop receptor, using molecular dynam-
ics simulations combined with functional data.
Molecular dynamics simulations have been used to ex-
plore a variety of ligand-receptor interactions over the last
decade (7,8), with ‘‘steered’’ molecular dynamics developed
speciﬁcally to simulate ligand unbinding from the receptor
(9). This method has been applied to various ligand-receptor
systems (10–12), for example, to examine unbinding of the
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streptavidin-biotin complex where the authors identiﬁed con-
formational changes of biotin during the unbinding process
and the breaking of hydrogen bonds between the ligand, the
receptor, and some surrounding water molecules (13). How-
ever, this method requires the predetermination of the un-
binding trajectory, which is not always possible. To overcome
this problem, the mutual repulsion method was developed to
allow the ligand to explore its own unbinding trajectory (14).
Here, the distance between the centers of mass of the ligand
and the receptor is incrementally increased during the course
of the simulation, but the method does not stipulate the exact
pathway. This prevents the imposition of a speciﬁc trajectory
of the unbinding process and allows the ligand to explore the
space available and locate its own optimum unbinding tra-
jectory. In this study, we have used this method to locate the
unbinding pathway of both an agonist (5-HT) and an an-
tagonist (granisetron) from their binding sites in the 5-HT3
receptor into the extracellular surroundings.
METHODS
Protein model
A high-resolution structure of the 5-HT3 receptor is not yet available, but the
molecular details of AChBP, a protein homologous to the extracellular
domain of this and other Cys-loop ligand-gated ion channel family mem-
bers, have been resolved (2). We used this structure to create a homology
model as previously described (15). Brieﬂy, the three-dimensional model of
the 5-HT3 receptor extracellular domain based on the structure of AChBP
was built using MODELLER (16). Sequence alignment was obtained using
the program FUGUE. The model was energy-minimized in SYBYL using
the AMBER force ﬁeld. The protein model has 5958 atoms, and it is a
cylinder of approximate dimensions 62 3 80 A˚.
Modiﬁed mutual repulsion simulation
Details of this method have been described previously (14). In the mutual
repulsion method, the centers of mass of the ligand and the receptor are
assigned what can be called ‘‘pseudocharges’’, g, that increase linearly with
time. A potential C(r) is deﬁned:
CðriÞ ¼ g
2
jR1  R2j ; (1)
where ri is the position vector of the atom i, g is the magnitude of the
pseudocharge at that time, R1 is the position vector of the center of mass of
the receptor, and R2 is that of the center of mass of the ligand.
The pseudocharges interact with each other, but do not affect the normal
electronic partial charges assigned to each atom. They repel or attract each
other under rules similar to those for normal electronic partial charges. This
method approaches the problem of unbinding as a rare event with a large
energy difference between the bound and the unbound states. The C(ri)
potential artiﬁcially reduces this energy difference so that the transition from
one state to another is facilitated. In addition, there are two advantages of the
method. First, since the force due to the pseudocharges is calculated with
respect to the centers of mass, no torque is generated on the molecules. The
molecules will be allowed to explore the unbinding path with fewer artiﬁcial
forces. Second, since the pseudocharge increases slowly, the potentialC(ri)
can be exploited for the calculation of the Helmholtz free energy by the
adiabatic switching method.
The position of 5-HT in the 5-HT3 receptor is shown in Fig. 1. The only
discernible opening in the extracellular domain is located toward the base of
the ligand binding site, and thus the force was directed to push the ligand out
of its binding site in this direction (z direction), although in some simulations
the direction was varied to ensure this did not bias the data. The protein was
centered with its ﬁvefold axis of symmetry coincident on the z axis, with its
extracellular side in the negative z direction and its membrane side in the
positive z direction. A point directly above the ligand in the negative z
direction was then used as the center of repulsion. The force on the protein
was artiﬁcially reduced to zero to prevent the receptor from spinning.
FIGURE 1 Schematic representation of the 5-HT3 receptor and the location
of amino acid residueswithin the proposed ligandunbindingpathway. (A) The
cartoon shows features of a typical 5-HT3 subunit. The residues associated
with ligand binding lie between the extracellular N-terminus and the ﬁrst
transmembrane-spanning region (M1). Attention has also been drawn to the
residues that line the channel pore (white cylinder), those associated with
selectivity (black lines either side of M2), and those that are associated with
channel conductance (--). The diagram at the upper right is a cross
section of the channel shown from above and demonstrates how ﬁve subunits
associate to form the central ion-conducting pore. (B) Residues implicated in
unbinding have been superimposed onto a 5-HT3 homology model that
includes the extracellular and transmembrane domains, but omits the
intracellular loop. The position of the membrane is shown as a light gray
box. Images of bound 5-HT (green) from the top, front, and base of the
binding site are shown as viewed from the direction of the arrows. 5-HT binds
at the interface of two adjacent subunits. For clarity, only two of the ﬁve
subunits required to create a functional receptor are shown and have been
colored in different shades of gray. The C-loop is superimposed in yellow.
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Simulation details
All simulations were carried out using a modiﬁed form of the DL_POLY
molecular dynamics simulation package (17) (see also http://www.cse.clrc.
ac.uk/msi/software/DL_POLY/), which incorporated the mutual repulsion
method. The CHARMm22 potential was used throughout (18). The cut-off
for the nonbonded interactions was 10 A˚, as used previously (11).
Two series of simulations were carried out. The ﬁrst was initiated using
an agonist (5-HT) docked into the binding site (15), and the second was
initiated with an antagonist (granisetron) docked into the same site (19). In
each simulation, the structure of the protein-ligand complex was minimized
for 20,000 steps using the zero-K minimization method. All nonhydrogen
atoms of the ligand and all Ca atoms of the protein were tethered to their
original positions using a harmonic potential. The structure with 5-HT
bound was heated to 310 K over 250 ps, followed by an equilibration period
of 100 ps. The granisetron-bound structure was heated to 310 K over 100 ps,
followed by an equilibrium period of 50 ps.
Two starting conditions were used after equilibration to examine their
effect on the ﬁnal unbinding trajectory. In the ﬁrst set of conditions, the
unbinding simulation continued from equilibration (no velocity rescaling),
and in the second set of conditions the velocities of all particles were
rescaled to 310 K at the beginning of the data production run (initial velocity
rescaling). In all simulations, unbinding forces were increased to achieve an
unbinding speed of ;20 m/s (0.20 A˚/ps). The time step of the simulation
was 1 fs. Data were recorded after the initial equilibration step with
conﬁguration-dumping every 1 ps. A Nose´-Hoover thermostat was applied
with a thermostat constant of 0.1 ps. All simulations were carried out in
vacuum. During the unbinding process, the tethering was reduced to the Ca
atoms of every ﬁfth amino acid; the atomic positions were allowed to deviate
from the initial position, but with an energy penalty that is a harmonic
potential. In half the simulations, the tethering remained unchanged during
the whole unbinding process (symmetric tethering). In the remaining
simulations, the tethering was lifted from the Ca atoms of these binding-path
amino acids (asymmetric tethering), allowing the system more ﬂexibility.
Hydrogen bond analysis
A hydrogen bond can be described as follows: B-A. . . .H-D, where A is an
acceptor atom, D is a donor atom, B is an atom immediately bonded to
A, and H is a hydrogen atom. The conditions for a hydrogen bond are met
when the following criteria are satisﬁed: 1), the distance between A and D is
,3.5 A˚; 2), the distance between A and H is,2.5 A˚; 3), the angle subtended
by atoms A, H, and D (conventionally known as u) is between 130 and
180; and 4), the angle subtended by atoms B, A, and H (conventionally
known as f) is between 90 and 180 (20). Note that for acceptor atoms that
are bonded to two atoms (such as the nitrogen on histidines), B is a dummy
atom created by taking the mean position of the two atoms bonded to
nitrogen.
Unbinding pathway
A computer program was written to construct a surface of the unbinding
pathway. The algorithm was inspired by an earlier work of Chau and Dean
(21). An axis was extended from one end of the pathway to the other end. At
regular intervals of 0.25 A˚, rays were drawn radially outward, normal to the
axis, at angular intervals of every 10. The point where the ray hits a van der
Waals surface of the protein atom is recorded. Together, the collection of
such points deﬁnes the unbinding tunnel. Cross-sectional areas of the tunnel
can also be readily computed at different points along the tunnel axis.
Cell culture and molecular biology
Human embryonic kidney HEK293 cells were grown on 90-mm tissue
culture plates at 37C and 7% CO2 in a humidiﬁed atmosphere. They were
cultured in DMEM/F12 (Dulbecco’s modiﬁed Eagle medium/nutrient mix
F12 (1:1)) with GLUTAMAX I containing 10% fetal calf serum, and
passaged when conﬂuent. At 70–80% conﬂuency, cells were transfected
with mutant or wild-type DNA by electroporation. Mutations were created
using the Kunkel method (22) using 5-HT3A(b) subunit DNA (accession
AY605711), as described previously (23).
FlexStation assays
These were as previously described (24). Brieﬂy, at 36–48 h posttransfec-
tion, cells were washed in ﬂex buffer (115 mM NaCl, 1 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES, pH 7.4) and 100 ml
of membrane potential dye (Molecular Devices, Wokingham, UK) was
added to each well. The plates were incubated at room temperature for 45–60
min before being placed in the FlexStation. Fluorescence was measured
every 2 s for a total experimental period of 200 s. At 20 s, 50 ml of either
agonist or ﬂex buffer was added to each well.
Softmax Pro (Molecular Devices) or PRISM (Graph Pad, San Diego,
CA) was used for data analysis. The percent change in ﬂuorescence, which
was calculated as F (peak ﬂuorescence) minus F0 (baseline ﬂuorescence at
20 s) divided by 5-HT Fmax (peak ﬂuorescence at 30 mM 5-HT), was
compared across 5-HT concentrations using F¼ Fmax/(I1 EC50/[5-HT]nH),
where I is the change in ﬂuorescence, EC50 is the concentration required for
the half-maximal response, and nH is the Hill coefﬁcient.
RESULTS
Protein structure
The all-atom root mean-square deviation of the simulated
protein structure during the unbinding events is shown in
Fig. 2. Data from the initial equilibration are omitted. During
the course of the simulation, the protein differed from the
original modeled structure by ;2.5 A˚, which shows that the
protein structure was preserved during the course of un-
binding in all eight simulations.
Unbinding trajectories
The trajectories of all eight unbinding simulations are shown
in Fig. 3 A, where each sphere shows the center of mass of
the ligand at 1-ps intervals during the course of unbinding.
The trajectories show that both ligands moved along a
similar vector that can be described as both downward and
outward from the center of the receptor. The trajectories were
very similar in the early stages, where the pathway was
enclosed by the C-loop, forming a tunnel of ;8 A˚ in length.
The entrance to the tunnel was at the end of the C-loop,;20
A˚ above the membrane, and the trajectories deviated from
each other beyond this point. Nevertheless, they were all
broadly similar, indicating that there was no signiﬁcant effect
of either velocity rescaling or the tethering scheme used. To
directly compare the different trajectories, amino acids within
5 A˚ of the ligand in the course of each trajectory were
identiﬁed (Tables 1 and 2). These data showed that a total of
52 different amino acids lay on the pathways, and 44% of
these were within 5 A˚ of the ligand in all eight unbinding
pathways. These can be considered as consensus residues and
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their positions are shown in Fig. 3 B. The majority of con-
sensus amino acids were located close to the binding pocket,
indicating a high degree of conformity in the unbinding
trajectories during the early stages of the unbinding process.
To verify that the ligand would only exit the binding site
along our proposed exit route, we simulated unbinding of the
ligand with the force directed toward the membrane (in the
negative z direction), inward (toward the ion channel), and
outward (away from the ion channel), and the results showed
that ligands did not exit the binding site through any other
path. Importantly, the ligands still followed the same tra-
jectories as those described above (data not shown).
Unbinding of 5-HT
The amino acids we previously identiﬁed as being within 5 A˚
of 5-HT in its correct orientation in the binding site are
marked in Table 1 (taken from model 4 of Reeves et al. (15)).
As expected, these amino acids interacted with the ligand at
the early stages of the simulation (white squares) but not at
the latter stages (black squares). Three overlapping frames of
the position of 5-HT at 0 ps, 48 ps, and 56 ps into the sim-
ulation (Fig. 4) show that the unbinding pathway follows the
tunnel described above. Forty-three amino acids were iden-
tiﬁed as being on the 5-HT unbinding pathways, with 74% of
these present in all four pathways.
The hydrogen-bonding pattern between the ligand and
the receptor on the exit pathway are shown in Table 3. The
hydrogen-bonding proﬁles of the four 5-HT trajectories were
qualitatively similar, so we have only presented the data for
5-HT unbinding from a symmetrically tethered protein with
no initial velocity rescaling. In the initial stages, the hydrogen
bonds formed between the ligand and the receptor were
similar to those reported in the literature (25). As the ligand
left the binding site, it turned slightly so that these inter-
actions were replaced by other hydrogen bonds. Of these, the
most persistent were those with E236, which initially acted
as a hydrogen-bond acceptor with the Hh of 5-HT, then HN2,
and ﬁnally HN3; Y153, which acts as a hydrogen-bond ac-
ceptor ﬁrst to HN2 and then to HN1 of 5-HT;W183, which acts
as an acceptor to HN1, HN2, and then HN3 of 5-HT; K238,
which acts as a donor to the O of 5-HT; and E129, which
hydrogen-bonds with HN1 and then with HN3. Thus, some of
the amino acids contributing to the hydrogen bonds are in the
enclosed part of the unbinding pathway, whereas others lie in
the groove that extends from this enclosed region toward the
membrane. There are no explicit waters in our simulations,
but given the size of 5-HT and the volume of the binding
pocket, it is unlikely that water would exist in this site.
FIGURE 2 Root mean-square deviation of the simulation structure during
the course of the experiment, compared to the original model. All atoms
are considered in the calculation. GRA, granisetron; asymt, asymmetric
tethering; symt, symmetric tethering; nvr, no velocity rescaling, vr, initial
velocity rescaling.
FIGURE 3 Unbinding trajectories and consensus amino acids in the
5-HT3 unbinding pathway. (A) Unbinding trajectories for 5-HT and
granisetron. Spheres represent the centers of mass of the ligand. All eight
simulations performed in this study are shown. (B) Residues from early
(yellow) and late (red) stages of the unbinding simulation. Residues within
this ﬁgure are shown in Tables 1 and 2.
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Q83 n n n
L126
N128y h h h h
E129 h h h h
F130 h
C162 n n n n
S163 n n n n




N174 n n n
S177 h h h h
T179y h h h h
T181y h h h h
S182y h h h h
W183y h h h h
L184y h h h h
H185 h
K224 h h h h
E225
F226y h h h h
S227
I228y h h h h
D229 h h h h




Y234y h h h h
A235 h
E236y h h h h
K238 h h h h
Y240 n n n n
I71 h h h h
Y73 h h h h
W90y h h h h
R92y h h h h
Y143y h h h h






S206 n n n n
I207 n n n n
F208 n n n n
I209 n n n n
N210 n n n n
Q211 n n n n
G212 n
Unbinding speed (m/s) 21 20 27 14
Residues present within the binding site during the early stages of the simulation are shown as white squares and later residues are shown as black squares. These
residues are also shown in Fig. 1. Residues that remain unhighlighted were identiﬁed in granisetron unbinding simulations, but were not identiﬁed during 5-HT
unbinding. Average unbinding speeds for the full trajectory of each simulation are shown in the bottom row of each column.
*Velocity rescaling was performed on these simulations.
yAmino acids previously identiﬁed as binding-site residues (15).
5-HT3 Receptor Exit Pathway 1983
Biophysical Journal 90(6) 1979–1991













N128 h h h h









S177 h h h h
T179y h h h h
T181y h h h h
S182y h h h h
W183y h h h h




F226 h h h h
S227 h h h h
I228y h h h h
D229y h h h h
I230y h h h h
S231 h h h
N232 h h h
S233 h
Y234y h h h h
A235 h
E236 h h h h
K238 h h h h
Y240
I71 h h
Y73 h h h h
W90y h h h h
R92y h h h h
Y143 h h h h
Y153y h h h h
L156 h h h
V201 h h h h
R202 h h h h
S203 n
K205 n n n n
S206y n n n n
I207 n n n n
F208 n n n n
I209 n n n n
N210 n n n
Q211 n
G212
Unbinding speed (m/s) 35 19 35 30
Residues that were present within the binding site during the early stages of the simulation are shown as white squares and later residues are shown as black
squares. These residues are also shown in Fig. 1. Residues that remain unhighlighted were seen in 5-HT unbinding simulations, but were not identiﬁed during
granisetron unbinding. Average unbinding speeds for the full trajectory of each simulation are shown in the bottom row of each column.
*Velocity rescaling was performed on these simulations.
yAmino acids previously identiﬁed as binding-site residues (15).
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Unbinding of granisetron
The amino acid residues identiﬁed as being within 5 A˚ of
docked granisetron in its correct orientation (19) are indi-
cated in Table 2. Similar to 5-HT unbinding, these residues
are seen to interact with the ligand in the early, but not the
late, stages of the simulation. The sole exception is residue
S206. This is interesting as it is located on the F-loop whose
position in the high-resolution structure of AChBP has not
yet been ﬁnalized. However, it is clear from our previous
studies that it plays a role in the binding and/or function of
the receptor (19) and our current data support this. Three
overlapping frames of the position of granisetron at 0 ps, 10
ps, and 55 ps into the simulation show that the unbinding
pathway is similar to that for 5-HT (Fig. 5). In total, 44 res-
idues were located on the granisetron unbinding pathways,
with 59% found in all four pathways.
The hydrogen bonds between granisetron and its receptor
during the course of unbinding are shown in Table 4. Similar
to 5-HT, the hydrogen-bonding proﬁles of the four granisetron
trajectories were qualitatively similar, so we have only pre-
sented the data for granisetron unbinding from an asymmet-
rically tethered protein with initial velocity rescaling. It can
be seen that granisetron establishes fewer hydrogen bonds
than 5-HT, perhaps because these are less important for
an antagonist as compared to an agonist. Throughout the sim-
ulation, there were only three hydrogen bonds and these
were between the hydrogen linked to the amide nitrogen of
granisetron and the Od1 of N128, between the indazole
nitrogen of granisetron and the hydroxyl group of Y153, and
the ammonium hydrogen of the azabicyclic ring and the
main-chain oxygen of I207.
Unbinding pathway
A reconstruction of the unbinding pathway from the original
homology model is shown in Fig. 6. Fig. 6, left, shows the
surface of the unbinding pathway looking from the extra-
cellular environment toward the outer surface of the 5-HT3
receptor, and Fig. 6, right, shows a cross-sectional area of the
pathway at different positions along its length. From the top
of the binding site, the pathway widens to a maximum of
;120 A˚2 at the location of Y153, constricts at the level of
I228, and then widens toward the mouth of the pathway. As
it proceeds closer to the membrane, the C-loop ends and the
tunnel that was present in the initial stages of the unbinding
process becomes a groove. The text and arrows in the center
of Fig. 6 show the location of the views in Fig. 7.
Comparison with previous docking models
The unbinding pathway is supported by our previous
ﬁndings from docking granisetron into the binding site
(19). In these studies, 13 energetically favorable models were
created and were found to fall into three main groups based
upon the orientation of granisetron in the binding site. Fig. 8
shows the position and orientation of granisetron in the three
model types. In model types A (Fig. 8 A) and B (Fig. 8 B), the
location of granisetron is broadly similar, with granisetron
docked high in the binding site, although the azabicyclic ring
is located at different ends of the binding pocket. In model
type C (Fig. 8 C), granisetron is located outside the binding
pocket in a region signiﬁcantly closer to the membrane. A
comparison of residues in model types A and B (yellow) and
model type C (red) is shown in Fig. 8 D (common residues
are shown in orange). Amino acids within models A and B
were almost all identiﬁed as residues that interacted in the
‘‘early’’ part of the granisetron unbinding simulation, whereas
amino acid residues close to the ligand in model type C
interact with the ligand later in the simulation. This indicates
that the potential binding site of granisetron shown in model
C is located on the unbinding pathway (Fig. 5).
Functional assays
Hydrogen-bonding data from the simulation study (Table 3)
showed that residues E236, W183, Y153, and K238 spent
the highest proportion of the total simulation time (27–47%)
bonding with 5-HT as it exited the binding site. Some
radioligand binding and functional data is already available
for receptors mutated at these positions and these data show
large changes in binding and functional properties of W183A
and Y153A mutant receptors (19,26–29). As the side chain
on alanine cannot form hydrogen bonds, these data are con-
sistent with our hypothesis that these residues may hydro-
gen-bond to 5-HT. Radioligand binding data are also available
for E236A and K238A mutant receptors and show no change
in binding afﬁnity compared to wild-type receptors (19).
However, our current data show large changes in EC50 in
both mutant receptors: E236A mutant receptors did not
function at concentrations up to 100 mM 5-HT, and K238A-
containing receptors had a 10-fold shift in EC50 (1.36 mM,
FIGURE 4 Movement of 5-HT during an unbinding simulation. For ease
of viewing only two subunits from the pentamer are shown. (A) A view from
the front of two adjacent subunits showing 5-HT at 0-ps (white ligand,
yellow amino acids), 48-ps (light gray ligand, orange amino acids) and 56-
ps (dark gray ligand, red amino acids) time intervals and highlighting that
the ligand moves both down and out during the unbinding process. (B) A
side view of the unbinding sequence shown in panel A.
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Y153 Oh 5-HT HN2
E236 Oe1 5-HT Hh
5-HT O K238 Hz1
W183 O 5-HT HN1
W183 O 5-HT HN2
W183 O 5-HT HN3
E236 Oe2 5-HT Hh
Y234 Oh 5-HT HN3
Y153 Oh 5-HT HN3
Y234 Oh 5-HT HN1
5-HT O K238 Hz2
T181 Og1 5-HT HN2
5-HT O K238 Hz3
E236 Oe1 5-HT HN2
T181 Og1 5-HT HN3
E129 Oe2 5-HT HN1
E236 Oe2 5-HT HN3
S206 O 5-HT He1
E236 Oe1 5-HT HN3
S163 O 5-HT Hh
5-HT O Q211 He22
5-HT O Q211 He21
E129 Oe1 5-HT HN3
S163 O 5-HT HN1
Q83 Oe1 5-HT Hh
5-HT O Q83 He22
The ﬁrst four columns identify the donor and acceptor atoms. The duration of the hydrogen bonds is indicated on the right. The protein was symmetrically
tethered and there was no velocity rescaling. The inset shows the structure of 5-HT, with potential hydrogen-bonding groups annotated in gray.
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compared to 0.2 mM for wild-type receptors). As EC50 is a
term that encompasses both binding and functional param-
eters, these data suggest that agonist binding or function is
impaired. They therefore support our hypothesis that hydro-
gen bonding with the agonist is important. Some hydrogen
bonding was also indicated between 5-HT and T181, S206,
Y234, E129, Q211, S163, and Q83. Examination of receptor
function when each of these residues was replaced by alanine
suggests that they may also hydrogen-bond to 5-HT: E129A,
Q83A, and S206Amutant receptors were nonfunctional up to
100 mM 5-HT, Y234A mutation caused a 70-fold increase in
EC50 (23), and T181A resulted in a 10-fold increase (EC50¼
1.95 mM). Q211A and S163A mutant receptors had EC50
values similar to wild-type receptors (0.17 and 0.24 mM,
respectively). These data are shown in Fig. 9.
DISCUSSION
This study has used molecular dynamics simulations to
provide a qualitative insight into the locations of both an
agonist and an antagonist as they exit the binding site of the
5-HT3 receptor. The data revealed that the exit pathway is a
tunnel formed at the interface of two subunits, which is
almost vertical with respect to the plane of the membrane. It
is;8 A˚ long and its entrance is;20 A˚ above the membrane.
These data are supported by functional studies.
The model that we have used to determine the unbinding
pathway is the homology model of the 5-HT3 receptor,
which is based on the structure of AChBP. AChBP has con-
siderable structural similarity with the extracellular domain
of the nACh receptor, and is a good template for the closely
related 5-HT3 receptor. However, as our data are based on a
model and not on an atomic resolution structure, caution
must be applied in interpreting molecular details. Indeed,
until a high-resolution structure is available, such studies can
only provide qualitative information, although some details
of molecular interactions can be obtained from experimental
studies. We have previously used such studies to show that
the predicted structure of the binding site is reasonably ac-
curate: Mutagenesis has demonstrated that many key residues
FIGURE 5 Movement of granisetron during an unbinding simulation. For
ease of viewing, only two subunits from the pentamer are shown. (A) A view
from the front of two adjacent subunits showing granisetron at 0-ps (white
ligand, yellow amino acids), 10-ps (light gray ligand, orange amino acids),
and 55-ps (dark gray ligand, red amino acids) time intervals. Similar to
5-HT (Fig 4), the ligand moves both down and out during the unbinding
process. (B) A side view of the unbinding sequence shown in panel A.









I207 O Granisetron Hk1
Granisetron Nd1 Y153 Hh
N128 Od1 Granisetron Hg
The ﬁrst four columns identify the donor and acceptor atoms. The duration of the hydrogen bonds is indicated on the right. The protein was symmetrically
tethered and there was no velocity rescaling. The inset shows the structure of granisetron, with potential hydrogen-bonding groups annotated in gray.
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identiﬁed in the binding pocket affect agonist and/or antag-
onist binding to the receptor. The roles of W183, Y143,
Y153, and Y234 have been particularly well studied, and
these data have shown that these residues form hydrogen
bonds and/or cation-p interactions with ligands (15,19,26,28).
Further studies in which all 26 residues proposed to form the
binding site were mutated provide yet more support for the
model (19).
The 5-HT3 receptor, like all Cys-loop receptors, exists in a
number of conformations, including an open, a closed, and
one or more desensitized states. It is not yet known how
much the structure of the protein varies in these different
states, although signiﬁcant changes in the nACh receptor
have been reported (30). AChBP has been proposed to be
similar to the open or desensitized state of the nACh re-
ceptor, and the location of residues that interact with 5-HT
when it is docked into the binding site of the AChBP-based
homology model are well supported by experimental evi-
dence, so our positioning of 5-HT in the binding site is
probably fairly accurate (1,2,31). Therefore, taking into
account the limitations mentioned above, the unbinding
pathway that we have identiﬁed is probably as accurate as the
structure and the molecular simulations allow, although, as
the closed state of the receptor has a distinct structure, it is
probably not a good representation of the binding pathway.
A recent study by Unwin (4) shows that in the resting state of
the nACh receptor, the C-loop points away from the center of
the receptor, ‘‘opening’’ the binding-site pocket and making
it more accessible. Consequently, it is possible that ligands
have a number of potential routes into the binding site, and
indeed, in the GABAA receptor it has been proposed that the
ligand accesses the binding site from the side (32). Maksay
et al. (25) alluded to the region we have identiﬁed as the entry
point of the ligand into the binding site (see Fig. 4 in that
article) but the new structural information better supports
ligands having a fairly unrestricted access (6). This is entirely
reasonable, as entry to the binding site must be rapid to
allow opening of the channel within milliseconds of agonist
application, whereas ligand unbinding is in the hundreds of
milliseconds to seconds time range (33–35). Structural data
suggest that in the ligand-bound conformation the C-loop has
closed over the ligand, restricting access to the binding site
and leaving only a narrow passage through which the ligand
can exit (Fig. 3). This exit route would place the ligand some
distance from the binding pocket and, we speculate, would
prevent immediate reentry of the ligand to the binding site
when the receptor reverts to the closed conformation.
There are as yet no high-resolution structural details of the
ligand binding pocket of any Cys-loop receptor with an-
tagonist bound. However, in the 5-HT3 receptor we antic-
ipate that this structure would be more similar to the open
than to the closed state, as our docking studies of granisetron
in the AChBP-like (open state) homology model are well
supported by experimental evidence (19). We therefore
believe that the starting location for granisetron that we used
for the simulations is broadly correct and that the pathway
we have identiﬁed is qualitatively accurate, although some
molecular details may vary. Support for this hypothesis
comes from docking studies with granisetron, where a po-
tential binding site for this molecule was located on the
unbinding pathway (19). A further binding site for another 5-
HT3 antagonist (tetrahydroacridine) has also been located on
our proposed pathway (36).
Of the residues thought to participate in the latter part
of the unbinding pathway, only S206 has previously been
shown to affect antagonist binding afﬁnity when mutated,
suggesting a role in binding and/or function of the 5-HT3
receptor (19). It is known from structural studies that this
residue is located within the F-loop, which is a ﬂexible
region in AChBP. F-loop residues have also been shown to
play a role in GABAA and nACh receptor function (37–39)
and consequently it is not surprising that mutations in this
region also have an effect on 5-HT3 receptor function.
Structural details of the F-loop region are poorly resolved in
the crystal structures of the AChBP (1,2) and in cryoelectron
microscopy images of the nACh receptor (6), suggesting that
the homology models may be inaccurate in this region.
However, there is increasing evidence from mutagenesis
and functional studies that this region undergoes structural
changes upon ligand binding.
FIGURE 6 Surface and cross-sectional area of
the unbinding pathway of the original homology
model. (Left) The surface of the unbinding
pathway is shown as viewed from the extracel-
lular environment, looking toward the C-loop of
the receptor. (Right) Cross-sectional area of the
ligand unbinding pathway immediately after the
initial 100-ps equilibration of 5-HT in the ligand
binding site. Text and arrows indicate the loca-
tions of the views shown in Fig 7.
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The tunnel that forms the exit route is considerably
shorter than the binding ‘‘gorge’’ described by Sussman
et al. (5) in acetylcholinesterase. This might be expected, as
in a ligand-gated receptor a neurotransmitter must be able to
enter and exit the binding site more rapidly than a substrate
or product of an enzymic reaction. Interestingly, both the
active site gorge and Cys-loop receptor binding sites are
dominated by aromatic amino acids, although there are
lower proportions of this type of amino acid in the
unbinding pathway, suggesting that hydrophobic interac-
tions have less importance here. However, there are many
potential hydrogen bonding partners for 5-HT on the
neurotransmitter unbinding pathway. Mutation of those
amino acids that dominate the hydrogen-bonding pattern
show that they play an important role in receptor function.
These data provide support for the pathway and also
suggest that these bonds may be more important than
aromatic interactions for the movement of the ligand in this
protein.
In conclusion, we have deﬁned a potential unbinding
pathway for ligands from the 5-HT3 receptor binding
pocket using molecular dynamics simulations. The routes
of both an agonist and an antagonist were similar, extending
from the ligand binding site down toward the membrane.
From these and other functional and structural data, we
propose the following model. The ligand enters the binding
site from one of several possible directions owing to the
open nature of the binding pocket in the extended C-loop
conformation. Ligand binding pulls the C-loop across the
pocket, closing access to the site, and, in the case of an
agonist, initiating a series of events that lead to channel
opening and subsequent receptor desensitization. The
ligand then leaves the binding pocket through the base of
the binding site, along the only pathway that remains
unobstructed after the movements of the extracellular
domain. This places the ligand some distance from the
binding site and the protein undergoes a conformational
change back into the closed, resting state.
FIGURE 8 (A–C) Comparison of residues within 5 A˚ of the ligand bind-
ing site from docked-pose clusters of models A, B, and C from Thompson
et al. (18). Granisetron is shown in blue. (D) A comparison of residues
that are involved with the docked-pose clusters A and B (yellow) and
cluster C (red). Residues that are common to both groups are highlighted
in orange.
FIGURE 7 Views of the unbinding pathway taken at different locations
along the unbinding trajectory. Images are representative of views taken at
3.5 A˚ (at the level of Y153), 6.5 A˚ (I228), and 10.5 A˚ (W90) from the ter-
minating residue located in the binding site. The positions from which these
views were taken are shown in Fig 6 and are shown immediately be-
fore unbinding, with 5-HT located in the binding site of the equilibrated
receptor.
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